|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-4-17
|
|
pubmed:abstractText |
The PREVENT III study was a prospective, randomized, double-blinded, multicenter phase III trial of a novel molecular therapy (edifoligide; E2F decoy) for the prevention of vein graft failure in patients undergoing infrainguinal revascularization for critical limb ischemia (CLI).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0741-5214
|
|
pubmed:author |
pubmed-author:BandykDennis FDF,
pubmed-author:BelkinMichaelM,
pubmed-author:BerceliScott ASA,
pubmed-author:BermanScott SSS,
pubmed-author:ClowesAlexander WAW,
pubmed-author:ConteMichael SMS,
pubmed-author:DeMasiRichard JRJ,
pubmed-author:HamdanAllen DAD,
pubmed-author:LorenzTodd JTJ,
pubmed-author:MonetaGregory LGL,
pubmed-author:NaminiHamidH,
pubmed-author:PREVENT III Investigators,
pubmed-author:RoddySean PSP,
pubmed-author:SamsonRussell HRH,
pubmed-author:SeelyLynnL
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
742-751; discussion 751
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16616230-Aged,
pubmed-meshheading:16616230-Aged, 80 and over,
pubmed-meshheading:16616230-Double-Blind Method,
pubmed-meshheading:16616230-E2F Transcription Factors,
pubmed-meshheading:16616230-Female,
pubmed-meshheading:16616230-Follow-Up Studies,
pubmed-meshheading:16616230-Graft Occlusion, Vascular,
pubmed-meshheading:16616230-Graft Rejection,
pubmed-meshheading:16616230-Graft Survival,
pubmed-meshheading:16616230-Humans,
pubmed-meshheading:16616230-Lower Extremity,
pubmed-meshheading:16616230-Male,
pubmed-meshheading:16616230-Middle Aged,
pubmed-meshheading:16616230-Peripheral Vascular Diseases,
pubmed-meshheading:16616230-Postoperative Complications,
pubmed-meshheading:16616230-Prospective Studies,
pubmed-meshheading:16616230-Reference Values,
pubmed-meshheading:16616230-Risk Assessment,
pubmed-meshheading:16616230-Severity of Illness Index,
pubmed-meshheading:16616230-Treatment Outcome,
pubmed-meshheading:16616230-Ultrasonography, Doppler,
pubmed-meshheading:16616230-Vascular Patency,
pubmed-meshheading:16616230-Vascular Surgical Procedures
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.
|
|
pubmed:affiliation |
Division of Vascular Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. mconte@partners.org
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III
|
